ArticleBlood cancer journal2026
Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis.
Abstract readLetter
In one paragraph
Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Histiocytosis development and clinical variation through the lens of genomics.The Journal of pathology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Paul G KempsDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands. p.g.kemps@lumc.nl.ORCID http://orcid.org/0000-0001-9793-7032
Jennifer L PicarsicDepartment of Pathology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-3718-6422
Sébastien HéritierDepartment of Pediatric Hematology and Oncology, Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID http://orcid.org/0000-0003-0384-6370
Jean DonadieuDepartment of Pediatric Hematology and Oncology, Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID http://orcid.org/0000-0002-4485-146X
Julien HarocheDepartment of Internal Medicine, University Hospital La Pitié-Salpêtrière Paris, French National Reference Center for Histiocytoses, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID http://orcid.org/0009-0003-9794-1316
Laure FarnaultDepartment of Hematology, La Conception, University Hospital of Marseille, Marseille, France.ORCID http://orcid.org/0000-0002-2612-7574
Stefania GaspariDepartment of Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-1387-0836
Dmitry A EvseevDmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID http://orcid.org/0000-0001-8610-0624
Daria S OsipovaDmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID http://orcid.org/0000-0002-9968-9332
Alexander E DruyDmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID http://orcid.org/0000-0003-1308-8622
Milen MinkovDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Oncology, Kepler University Hospital, Linz, Austria.ORCID http://orcid.org/0000-0001-6471-8423
Susan PictonDepartment of Pediatric Oncology and Hematology, Leeds Children's Hospital, Leeds, UK.
Andreas BeilkenDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0009-0004-3739-6093
Robert MöhleDepartment of Hematology and Oncology, University Hospital Tuebingen, Tuebingen, Germany.
Miloš B KuzmanovićMother and Child Health Care Institute of Serbia "Dr. Vukan Čupić", Belgrade, Serbia.ORCID http://orcid.org/0000-0002-6921-1717
Hitomi S OkumaDepartment of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9639-7361
Chung W ChowDepartment of Anatomical Pathology, Royal Children's Hospital, Melbourne, VIC, Australia.
Martin A CampbellDepartment of Oncology, Royal Children's Hospital, Melbourne, VIC, Australia.
Gregory S PhillipsDepartment of Dermatology, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0009-0000-9028-2504
Yuhang ZhouDepartment of Oncology, University of Texas at Austin, Austin, TX, USA.
Gaurav GoyalDepartment of Medicine, Division of Hematology and Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0001-6148-5177
Ronald S GoDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-8284-3495
Kee Kiat YeoDepartment of Pediatric Oncology, Dana Farber/Boston Children's Cancer and Blood Disorders Center, Massachusetts, MA, USA.ORCID http://orcid.org/0000-0003-0713-6384
Bryan A SiskDepartment of Pediatrics, Division of Hematology and Oncology, Washington University in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-2456-2476
Joanna L WeinsteinDepartment of Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-0585-9669
Patrick K CampbellDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-2198-5991
Eli L DiamondDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-5456-5961
Jean-François EmileParis-Saclay University, Versailles SQY University, INSERM U981, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise Paré Hospital, Smart Imaging, Pathology Department, Boulogne, France. jean-francois.emile@uvsq.fr.ORCID http://orcid.org/0000-0002-6073-4466
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MAmerican Cancer Society (American Cancer Society, Inc.) RSG-24-1317006-01-CTPSInstitut National Du Cancer (French National Cancer Institute) PRT-K19-143Leukemia and Lymphoma Society (Leukemia & Lymphoma Society) Career Development ProgramNCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.